ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/03/23 | 2,242 | 2,269 | 2,208 | 2,213 | -15 | -0.7% | 55,500 |
2021/03/22 | 2,194 | 2,238 | 2,174 | 2,228 | +25 | +1.1% | 83,100 |
2021/03/19 | 2,193 | 2,211 | 2,162 | 2,203 | +3 | +0.1% | 125,200 |
2021/03/18 | 2,222 | 2,229 | 2,194 | 2,200 | -18 | -0.8% | 86,600 |
2021/03/17 | 2,198 | 2,226 | 2,188 | 2,218 | +26 | +1.2% | 83,400 |
2021/03/16 | 2,132 | 2,192 | 2,132 | 2,192 | +53 | +2.5% | 91,100 |
2021/03/15 | 2,103 | 2,141 | 2,102 | 2,139 | +37 | +1.8% | 70,400 |
2021/03/12 | 2,134 | 2,134 | 2,097 | 2,102 | -47 | -2.2% | 76,000 |
2021/03/11 | 2,150 | 2,154 | 2,133 | 2,149 | +15 | +0.7% | 66,800 |
2021/03/10 | 2,122 | 2,149 | 2,108 | 2,134 | -24 | -1.1% | 80,200 |
2021/03/09 | 2,113 | 2,166 | 2,090 | 2,158 | +95 | +4.6% | 134,700 |
2021/03/08 | 2,056 | 2,069 | 2,040 | 2,063 | +15 | +0.7% | 44,000 |
2021/03/05 | 2,028 | 2,048 | 2,026 | 2,048 | +19 | +0.9% | 80,900 |
2021/03/04 | 2,017 | 2,030 | 2,012 | 2,029 | -5 | -0.2% | 38,800 |
2021/03/03 | 2,025 | 2,036 | 2,012 | 2,034 | +9 | +0.4% | 46,600 |
2021/03/02 | 2,019 | 2,034 | 2,010 | 2,025 | +10 | +0.5% | 70,400 |
2021/03/01 | 1,997 | 2,018 | 1,992 | 2,015 | +18 | +0.9% | 105,500 |
2021/02/26 | 2,025 | 2,031 | 1,997 | 1,997 | -25 | -1.2% | 159,800 |
2021/02/25 | 2,048 | 2,053 | 2,022 | 2,022 | -11 | -0.5% | 72,000 |
2021/02/24 | 2,024 | 2,043 | 2,008 | 2,033 | +9 | +0.4% | 80,900 |
2021/02/22 | 2,012 | 2,043 | 2,012 | 2,024 | +2 | +0.1% | 46,600 |
2021/02/19 | 2,018 | 2,031 | 2,010 | 2,022 | -5 | -0.2% | 59,900 |
2021/02/18 | 2,027 | 2,036 | 2,016 | 2,027 | -13 | -0.6% | 46,200 |
2021/02/17 | 2,040 | 2,052 | 2,028 | 2,040 | -14 | -0.7% | 32,300 |
2021/02/16 | 2,059 | 2,059 | 2,037 | 2,054 | -7 | -0.3% | 29,400 |
2021/02/15 | 2,081 | 2,081 | 2,043 | 2,061 | -8 | -0.4% | 61,800 |
2021/02/12 | 2,100 | 2,101 | 2,062 | 2,069 | -26 | -1.2% | 42,200 |
2021/02/10 | 2,089 | 2,117 | 2,086 | 2,095 | +9 | +0.4% | 45,200 |
2021/02/09 | 2,122 | 2,163 | 2,082 | 2,086 | -79 | -3.6% | 114,400 |
2021/02/08 | 2,053 | 2,175 | 2,053 | 2,165 | +156 | +7.8% | 191,500 |
2021/02/05 | 1,998 | 2,022 | 1,987 | 2,009 | +17 | +0.9% | 71,100 |
2021/02/04 | 1,996 | 2,008 | 1,991 | 1,992 | -26 | -1.3% | 33,000 |
2021/02/03 | 2,014 | 2,024 | 2,010 | 2,018 | +18 | +0.9% | 40,500 |
2021/02/02 | 1,990 | 2,020 | 1,985 | 2,000 | +7 | +0.4% | 41,800 |
2021/02/01 | 1,991 | 2,009 | 1,991 | 1,993 | +2 | +0.1% | 43,400 |
2021/01/29 | 2,015 | 2,045 | 1,991 | 1,991 | -31 | -1.5% | 65,200 |
2021/01/28 | 1,973 | 2,034 | 1,968 | 2,022 | +47 | +2.4% | 122,000 |
2021/01/27 | 1,948 | 1,980 | 1,945 | 1,975 | +30 | +1.5% | 85,600 |
2021/01/26 | 1,935 | 1,950 | 1,933 | 1,945 | +19 | +1% | 68,100 |
2021/01/25 | 1,919 | 1,928 | 1,913 | 1,926 | +19 | +1% | 29,300 |
2021/01/22 | 1,918 | 1,921 | 1,907 | 1,907 | -21 | -1.1% | 71,800 |
2021/01/21 | 1,915 | 1,938 | 1,915 | 1,928 | +12 | +0.6% | 77,000 |
2021/01/20 | 1,906 | 1,919 | 1,899 | 1,916 | +10 | +0.5% | 53,100 |
2021/01/19 | 1,918 | 1,918 | 1,902 | 1,906 | -5 | -0.3% | 76,200 |
2021/01/18 | 1,906 | 1,916 | 1,902 | 1,911 | +5 | +0.3% | 45,200 |
2021/01/15 | 1,922 | 1,922 | 1,906 | 1,906 | -20 | -1% | 59,900 |
2021/01/14 | 1,915 | 1,927 | 1,910 | 1,926 | +11 | +0.6% | 82,800 |
2021/01/13 | 1,920 | 1,920 | 1,906 | 1,915 | -20 | -1% | 92,500 |
2021/01/12 | 1,920 | 1,949 | 1,912 | 1,935 | +16 | +0.8% | 75,300 |
2021/01/08 | 1,917 | 1,928 | 1,907 | 1,919 | +2 | +0.1% | 78,200 |
901~
950
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム